EUSEBI, PAOLO
 Distribuzione geografica
Continente #
NA - Nord America 4.339
EU - Europa 3.494
AS - Asia 3.091
SA - Sud America 492
AF - Africa 79
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 3
Totale 11.504
Nazione #
US - Stati Uniti d'America 4.235
SG - Singapore 1.459
IT - Italia 1.216
IE - Irlanda 553
CN - Cina 447
BR - Brasile 384
HK - Hong Kong 370
RU - Federazione Russa 360
VN - Vietnam 352
FR - Francia 261
DE - Germania 237
UA - Ucraina 194
FI - Finlandia 136
GB - Regno Unito 111
SE - Svezia 102
IN - India 96
NL - Olanda 75
KR - Corea 55
TR - Turchia 50
BD - Bangladesh 48
CA - Canada 45
IQ - Iraq 45
RO - Romania 41
AR - Argentina 38
PL - Polonia 36
MX - Messico 35
JP - Giappone 33
AT - Austria 29
ES - Italia 29
CH - Svizzera 26
ZA - Sudafrica 26
CZ - Repubblica Ceca 23
PK - Pakistan 20
VE - Venezuela 18
UZ - Uzbekistan 17
CO - Colombia 16
BE - Belgio 15
ID - Indonesia 15
LT - Lituania 15
CL - Cile 12
JO - Giordania 11
SA - Arabia Saudita 10
MA - Marocco 9
DZ - Algeria 8
EC - Ecuador 8
GR - Grecia 8
PH - Filippine 7
TN - Tunisia 7
AL - Albania 6
KE - Kenya 6
KG - Kirghizistan 6
PY - Paraguay 6
AU - Australia 5
AZ - Azerbaigian 5
ET - Etiopia 5
JM - Giamaica 5
LB - Libano 5
SY - Repubblica araba siriana 5
UY - Uruguay 5
CI - Costa d'Avorio 4
EG - Egitto 4
IL - Israele 4
MY - Malesia 4
NP - Nepal 4
OM - Oman 4
SI - Slovenia 4
AE - Emirati Arabi Uniti 3
BG - Bulgaria 3
CR - Costa Rica 3
HN - Honduras 3
HR - Croazia 3
NI - Nicaragua 3
PA - Panama 3
SN - Senegal 3
BH - Bahrain 2
BO - Bolivia 2
DK - Danimarca 2
EU - Europa 2
GA - Gabon 2
HU - Ungheria 2
KZ - Kazakistan 2
PE - Perù 2
SV - El Salvador 2
TJ - Tagikistan 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BS - Bahamas 1
BY - Bielorussia 1
CY - Cipro 1
DM - Dominica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GE - Georgia 1
GH - Ghana 1
GY - Guiana 1
KW - Kuwait 1
LC - Santa Lucia 1
LK - Sri Lanka 1
LV - Lettonia 1
Totale 11.490
Città #
Singapore 1.082
Chandler 650
Dublin 553
San Jose 368
Hong Kong 364
Perugia 302
Ashburn 299
San Mateo 258
Boardman 182
Santa Clara 147
Moscow 138
Altamura 135
Wilmington 129
Beijing 126
Dong Ket 121
Medford 113
Princeton 112
Lauterbourg 103
Munich 97
Lawrence 95
Jacksonville 91
Des Moines 80
Ho Chi Minh City 78
Los Angeles 74
Andover 69
Milan 67
Rome 59
Hanoi 56
The Dalles 56
Seoul 55
New York 52
Ann Arbor 47
Helsinki 41
São Paulo 38
Turku 35
Frankfurt am Main 32
Bucharest 30
Orem 27
Houston 26
Tokyo 26
Chennai 25
Atlanta 24
Dallas 23
Norwalk 23
Poplar 23
Saint Petersburg 23
Brooklyn 22
Denver 22
Izmir 22
Nuremberg 22
Bologna 21
Chicago 21
Salerno 21
Warsaw 20
Falls Church 19
Baghdad 18
Council Bluffs 18
Amsterdam 17
Phoenix 17
Piscataway 17
Mexico City 16
Montreal 16
Brussels 15
Genoa 15
Seattle 15
Stockholm 15
Brno 14
Falkenstein 14
Haiphong 14
Johannesburg 14
London 14
Redwood City 14
Verona 14
Vienna 14
Boston 13
San Paolo di Civitate 13
Turin 13
Ankara 12
Dearborn 12
Manchester 12
Modena 12
Amman 11
San Francisco 11
Shanghai 11
Hefei 10
New Delhi 10
Saint Louis 10
Tashkent 10
Columbus 9
Lausanne 9
Padova 9
Rio de Janeiro 9
Toronto 9
Belo Horizonte 8
Caracas 8
Catania 8
Mumbai 8
Naples 8
Parma 8
Trento 8
Totale 7.296
Nome #
The validation of an Italian version of the Freezing of Gait Questionnaire 756
CSF and blood biomarkers for Parkinson's disease 198
Deviation from intention to treat analysis in randomised trials and treatment effect estimates: meta-epidemiological study 161
A diagnostic accuracy study validating cardiovascular ICD-9-CM codes in healthcare administrative databases. The Umbria data-value project 161
Accuracy of ICD-9 codes in identifying patients with peptic ulcer and gastrointestinal hemorrhage in the regional healthcare administrative database of Umbria 147
Time trends, frequency, characteristics and prognosis of short-duration transient global amnesia 143
Interatrial Shunting Through an Asymptomatic Patent Foramen Ovale in Thoracic Surgery 139
Cerebrospinal fluid free light chains compared to oligoclonal bands as biomarkers in multiple sclerosis 138
Validating malignant melanoma ICD-9-CM codes in Umbria, ASL Napoli 3 Sud and Friuli Venezia Giulia administrative healthcare databases: a diagnostic accuracy study 137
Disturbi del comportamento alimentare nei maschi: l'importanza della distorsione dell'immagine corporea. 133
Cerebrospinal fluid β-glucocerebrosidase activity is reduced in parkinson's disease patients 133
Diagnostic performance of a fully automated chemiluminescent enzyme immunoassay for Alzheimer's disease diagnosis 133
Characterization of Brain Lysosomal Activities in GBA-Related and Sporadic Parkinson’s Disease and Dementia with Lewy Bodies 130
Brain arteriovenous malformations and seizures: an Italian study. 128
A magnetization transfer study of mild and advanced Parkinson's disease. 124
Selective loss of glucocerebrosidase activity in sporadic Parkinson's disease and dementia with Lewy bodies 123
A new enzyme-linked immunosorbent assay for neurofilament light in cerebrospinal fluid: analytical validation and clinical evaluation 122
Cerebrospinal fluid neurofilament light chain tracks cognitive impairment in multiple sclerosis 122
Substantia nigra hyperechogenicity in essential tremor and Parkinson's disease: a longitudinal study 120
Cerebrospinal fluid lysosomal enzymes and α-synuclein in Parkinson's disease. 119
Dural arteriovenous fistulas and headache features: an observational study 119
The added value of Aβ42/Aβ40 in the CSF signature for routine diagnostics of Alzheimer's disease 119
Validity of cerebrovascular ICD-9-CM codes in healthcare administrative databases. The Umbria Data-Value Project 118
Performance of Aβ1-40, Aβ1-42, Total Tau, and Phosphorylated Tau as Predictors of Dementia in a Cohort of Patients with Mild Cognitive Impairment. 117
Alzheimer's disease and late-onset epilepsy of unknown origin: two faces of beta amyloid pathology 116
Multilevel Latent Class Models for evaluation of long term care facilities 115
2017 revisions of McDonald criteria shorten the time to diagnosis of multiple sclerosis in clinically isolated syndromes 114
Diagnostic utility of cerebrospinal fluid α-synuclein in Parkinson's disease: A systematic review and meta-analysis 113
Occipital arteriovenous malformations andmigraine. 112
Reliability and validity of the Italian versions of the Children's Fear Survey Schedule Dental Subscale and the Modified Child Dental Anxiety Scale 112
Cerebrospinal fluid hemoglobin levels as markers of blood contamination: relevance for α-synuclein measurement 112
Cerebrospinal fluid biomarkers for the diagnosis and prognosis of Parkinson's disease: protocol for a systematic review and individual participant data meta-analysis 111
Cerebrospinal fluid Tau/α-synuclein ratio in Parkinson's disease and degenerative dementias. 109
Applicazione della Scala Sulla Qualita della vita nelle residenze protette dell'Umbria 108
Health technology disinvestment worldwide: Overview of programs and possible determinants 108
Extracranial Venous Drainage Pattern in Multiple Sclerosis and Healthy Controls: Application of the 2011 Diagnostic Criteria for Chronic Cerebrospinal Venous Insufficiency 108
Predictive value of admission blood glucose level on short-term mortality in acute cerebral ischemia. 107
Changes in endolysosomal enzyme activities in cerebrospinal fluid of patients with Parkinson's disease. 107
Changes of olfactory tract in Parkinson’s disease: a DTI tractography study 107
A 1H magnetic resonance spectroscopy study in patients with obstructive sleep apnea. 106
Lower urinary tract symptoms and urodynamic dysfunction in clinically isolated syndromes suggestive of multiple sclerosis 106
Cerebrospinal fluid biomarkers in Alzheimer's and Parkinson's diseases-From pathophysiology to clinical practice 106
The Italian version of cognitive function instrument (CFI): reliability and validity in a cohort of healthy elderly 105
T2*-weighted MRI values correlate with motor and cognitive dysfunction in Parkinson's disease 105
Stima della non autosufficienza negli anziani in Umbria 104
Oral health knowledge level of nursing staff working in semi-intensive heart failure units 104
The Italian version of Cognitive Function Instrument (CFI) for tracking changes in healthy elderly: results at 1-year follow-up 104
Prevalence and risk of progression of preclinical Alzheimer's disease stages: A systematic review and meta-analysis 103
Association between migraine and headache attributed to stroke: a case-control study. 102
Lysosomal enzyme activities in human brain 101
Epilepsy, amyloid-β, and D1 dopamine receptors: a possible pathogenetic link? 101
Cerebrospinal Fluid Biomarkers in Alzheimer's Disease: An Invaluable Tool for Clinical Diagnosis and Trial Enrichment 101
Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer's disease core biomarkers in Lewy body disorders and Alzheimer's dementia 101
Fingerprinting Alzheimer's Disease by 1H Nuclear Magnetic Resonance Spectroscopy of Cerebrospinal Fluid 100
White Matter Hyperintensities Are No Major Confounder for Alzheimer's Disease Cerebrospinal Fluid Biomarkers 100
Distorsione dell'immagine corporea nei DCA nei maschi 99
Cerebrospinal Fluid Aβ42/40 Corresponds Better than Aβ42 to Amyloid PET in Alzheimer's Disease 99
Long-Term Risk of Stroke After Transient Global Amnesia in Two Prospective Cohorts 97
Impulse Control Disorders and Levodopa-Induced Dyskinesias in Parkinson's Disease: Pulsatile versus Continuous Dopaminergic Stimulation 97
Performance Evaluation of an Automated ELISA System for Alzheimer's Disease Detection in Clinical Routine 96
Treatment of multiple sclerosis relapses with high-dose methylprednisolone reduces the evolution of contrast-enhancing lesions into persistent black holes 96
Synaptic vesicle protein 2A tumoral expression predicts levetiracetam adverse events 96
Liverpool Adverse Events Profile: Italian validation and predictive value for dropout from antiepileptic treatment in people with epilepsy 95
Novel noninvasive biomarkers of prodromal Alzheimer disease: The role of optical coherence tomography and optical coherence tomography–angiography 95
Cerebrospinal fluid and serum D-serine concentrations are unaltered across the whole clinical spectrum of Alzheimer's disease 94
A systematic review found that deviations from intention-to-treat are common in randomized trials and systematic reviews 92
Protocol for validating cardiovascular and cerebrovascular ICD-9-CM codes in healthcare administrative databases: The Umbria Data Value Project 92
Underrecognition and undertreatment of dementia in Italian nursing homes. 91
Obsessive-compulsive disorder and migraine with medication-overuse headache. 88
New pathological findings in an international cohort of hereditary spastic paraplegia 4 patients. 86
Diagnostic utility of CSF α-synuclein species in Parkinson's disease: Protocol for a systematic review and meta-analysis 86
Reciprocal Incremental Value of 18F-FDG-PET and Cerebrospinal Fluid Biomarkers in Mild Cognitive Impairment Patients Suspected for Alzheimer's Disease and Inconclusive First Biomarker 86
Stopping onabotulinum treatment after the first two cycles might not be justified: Results of a real-life monocentric prospective study in chronic migraine 85
Parkinson's and Lewy body dementia CSF biomarkers 85
Improved Cerebrospinal Fluid-Based Discrimination between Alzheimer's Disease Patients and Controls after Correction for Ventricular Volumes 84
Evidence of practice effect in CANTAB spatial working memory test in a cohort of patients with mild cognitive impairment 84
Early management of patients with medication-overuse headache: results from a multicentre clinical study 84
Incidence and Antiseizure Medications of Post-stroke Epilepsy in Umbria: A Population-Based Study Using Healthcare Administrative Databases 83
Cerebrospinal fluid neurofilament light chain predicts disease activity after the first demyelinating event suggestive of multiple sclerosis 81
Misure relative all'obiettivo di salute numero uno del PSR 2003-2005: aspettativa di vita con e senza disabilità nella popolazione umbra. Anni 1999-2000 e 2004-2005 80
Neuropsychiatric adverse events of antiepileptic drugs in brain tumour-related epilepsy: an Italian multicentre prospective observational study 80
Drug-dependence behaviour and outcome of medication-overuse headache after treatment 79
Risk factors of levodopa-induced dyskinesia in Parkinson's disease: results from the PPMI cohort 79
The possible role of Optical Coherence Tomography (OCT) and OCT‐Angiography (OCTA) as new non‐invasive biomarkers of prodromal Alzheimer’s disease 79
Le condizioni di salute della popolazione anziana 78
Factors influencing the measurement of lysosomal enzymes activity in human cerebrospinal fluid. 78
High risk of early conversion to multiple sclerosis in clinically isolated syndromes with dissemination in space at baseline 78
Fibroblast growth factor-2 levels are elevated in the cerebrospinal fluid of multiple sclerosis patients. 77
Degradation of endocannabinoids in chronic migraine and medication overuse headache. 77
Condizioni di salute della popolazione anziana in Umbria negli anni 2004-2005 77
Cerebrospinal Fluid Biomarkers for Target Engagement and Efficacy in Clinical Trials for Alzheimer's and Parkinson's Diseases 76
Differential role of CSF alpha-synuclein species, tau, and Aβ42 in Parkinson's Disease. 75
Subclinical vestibular dysfunction in migraineurs without vertigo: A Clinical study 75
Longitudinal changes in CSF alpha-synuclein species reflect Parkinson's disease progression 75
Stima della non autosufficienza negli anziani in Umbria 73
Multilevel Latent Class Models for evaluation of long term care facilities 73
Discovery, validation and optimization of cerebrospinal fluid biomarkers for use in Parkinson’s disease 73
Antiepileptic drugs in migraine and epilepsy: Who is at increased risk of adverse events? 73
Le condizioni di salute della popolazione anziana in Umbria 70
Immunological profile of silent brain infarction and lacunar stroke. 69
Totale 10.913
Categoria #
all - tutte 48.100
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.100


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021186 0 0 0 0 0 0 0 0 0 17 31 138
2021/20221.066 10 189 10 26 39 15 17 279 42 74 197 168
2022/20232.007 123 392 27 173 131 246 6 94 712 5 58 40
2023/2024884 40 82 39 28 18 21 197 38 42 42 150 187
2024/20252.038 48 142 82 132 211 151 111 179 369 124 318 171
2025/20264.190 274 279 245 544 654 410 661 251 542 330 0 0
Totale 11.844